Msh2-deficient thymic lymphomas are thought to represent a single histopathologic entity and the tumor homogeneity suggests specific recurring genetic events may underlie the lymphocyte transformation and expression of a malignant phenotype [20]. The gene discussed is MSH2; the disease is thymus lymphoma.